Efficacy and Safety of BG00012 in MS

Clinical trial NCT00168701 · COMPLETED

Trial details

NCT number: NCT00168701
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2004-10-01
Primary completion: 2006-03-31
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.